Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a super multivitamin give babies a healthier start in life?

NCT ID NCT07029282

Disease control Sponsor: Aga Khan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a new multivitamin supplement (MMS Plus) given during pregnancy and after birth can improve infant health and growth compared to standard multivitamins or iron/folic acid. About 3,000 pregnant women in Pakistan will take the supplements and be followed until their babies are 6 months old. The goal is to reduce complications like stillbirth, preterm birth, and poor growth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multiple micronutrient supplements (MMS Plus, standard MMS, and iron/folic acid)
What this could lead to
If it works, this could point toward a better prenatal and postnatal supplement to reduce infant deaths and improve growth in low-resource settings.
What could go wrong
This is a large phase 3 trial, but results may not apply to other populations. The supplements are generally safe, but individual allergies or intolerances are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 49 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Antenatal Phase:: Inclusion Criteria: * Gestational age confirmed by ultrasound to be 8-14 weeks * Singleton and viable fetus on ultrasound * A resident of the catchment area for at least the last six months * Plans to stay within the catchment area during the pregnancy duration, during delivery and after birth of the baby. * Has provided voluntary written informed consent Exclusion Criteria: * Women with known allergies or intolerance to any components of the MMS or MMS PLUS being studied * Women with pre-existing health conditions such as history of uncontrolled diabetes and hypertension or other chronic illnesses * Substance abuse, such as recreational drugs or smoking tobacco. Women chewing tobacco will not be excluded. Postnatal Phase:: Inclusion Criteria: * Birth weight available within 72 hours * Intention to breastfeed for 6 months * Resides in the study area for the duration of the trial * Has provided voluntary written informed consent Exclusion Criteria: * Congenital anomalies, birth defects, or severe neonatal complications * Infants who are already receiving supplemental formula feeding or other nutritional supplements (except pre-lacteal feeding, vitamins, and medications) * Infants whose mothers have conditions that significantly affect breastfeeding, such as severe postpartum depression, insufficient milk supply, or maternal use of medications that contraindicate breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adaptive trial are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adaptive trial Multiple micronutrient deficiencies during pregnancy Neurodevelopment outcome Newborn health Nutrition during pregnancy Postnatal growth

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Peri-Urban Slums of Karachi (Ali Akber Shah, Bhains Colony)

    RECRUITING

    Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.